Literature DB >> 8660151

An increased frequency of patent foramen ovale in patients with transient global amnesia. Analysis of 53 consecutive patients.

C Klötzsch1, U Sliwka, P Berlit, J Noth.   

Abstract

OBJECTIVE: Alerted by the number of patients with transient global amnesia (TGA) in whom Valsalvalike activities immediately preceded the onset of TGA, we have investigated the frequency of patent foramen ovale (PFO) as the prerequisite for paradoxical embolism.
DESIGN: Case series with comparison to a control group.
SETTING: Hospitalized and ambulatory patients at the neurological departments of the Alfried Krupp Hospital, Essen, Germany, and the Rheinisch-Westfälische-Technische Hochschule, Aachen, Germany. PATIENTS: Fifty-three consecutive patients with TGA were evaluated by the 2 centers between 1988 and 1995.
RESULTS: Using contrast transcranial Doppler sonography we have observed a PFO in 55% of the patients with TGA, compared with 27% of a control group of 100 patients. This difference was statistically significant (P < .01). Twenty-five patients with TGA (47%), 15 of them with a proven PFO, reported a precipitating activity, such as the lifting of heavy weights, immediately before the TGA occurred.
CONCLUSIONS: In addition to other pathological mechanisms, paradoxical embolism with temporobasal ischemia could possibly play a role in the clinical syndrome of TGA. This hypothesis could explain the frequent observation of preceding Valsalvalike activities in patients with TGA.

Entities:  

Mesh:

Year:  1996        PMID: 8660151     DOI: 10.1001/archneur.1996.00550060046014

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  9 in total

1.  Weather conditions and transient global amnesia. A six-year study.

Authors:  N Maalikjy Akkawi; C Agosti; M Grassi; B Borroni; A Pezzini; L A Vignolo; A Padovani
Journal:  J Neurol       Date:  2005-08-24       Impact factor: 4.849

Review 2.  Patent foramen ovale: anatomy, outcomes, and closure.

Authors:  Patrick A Calvert; Bushra S Rana; Anna C Kydd; Leonard M Shapiro
Journal:  Nat Rev Cardiol       Date:  2011-02-01       Impact factor: 32.419

3.  Long-Term Outcome in Patients With Transient Global Amnesia: A Population-Based Study.

Authors:  Julieta E Arena; Robert D Brown; Jay Mandrekar; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2017-02-06       Impact factor: 7.616

Review 4.  Classical diseases revisited: transient global amnesia.

Authors:  D Owen; B Paranandi; R Sivakumar; M Seevaratnam
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

5.  Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura.

Authors:  P T Wilmshurst; M J Pearson; S Nightingale; K P Walsh; W L Morrison
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

6.  Transient global amnesia during transoesophageal echocardiogram.

Authors:  Paolo Profice; Vittoria Rizzello; Faustino Pennestrì; Fabio Pilato; Giacomo Della Marca; Alfonso Sestito; Filippo Crea; Pietro A Tonali; Vincenzo Di Lazzaro
Journal:  Neurol Sci       Date:  2008-11-24       Impact factor: 3.307

7.  Subarachnoid hemorrhage after transient global amnesia caused by cerebral venous congestion: case report.

Authors:  Yuta Maetani; Masahiro Nakamori; Tomoaki Watanabe; Hayato Matsushima; Eiji Imamura; Shinichi Wakabayashi
Journal:  BMC Neurol       Date:  2018-04-06       Impact factor: 2.474

Review 8.  Transient global amnesia: current perspectives.

Authors:  David R Spiegel; Justin Smith; Ryan R Wade; Nithya Cherukuru; Aneel Ursani; Yuliya Dobruskina; Taylor Crist; Robert F Busch; Rahim M Dhanani; Nicholas Dreyer
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-24       Impact factor: 2.570

9.  No evidence of jugular venous valve insufficiency in patients with migraine--a controlled study.

Authors:  Kasja Rabe; Michael Küper; Dagny Holle; Irini Savidou; Oliver Kastrup; Andreas Jähne-Blasberg; Hans Christoph Diener; Zaza Katsarava; Markus Frings
Journal:  J Headache Pain       Date:  2013-06-19       Impact factor: 7.277

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.